Expression and function of the transient receptor potential ion channel family in the hematologic malignancies

Current Molecular Pharmacology

Volumn 6, Issue 3, 2013, Pages 137-148

  Morelli, Maria B ^a   Liberati, Sonia ^a,b   Amantini, Consuelo ^a   Nabiss, Massimo ^a   Santoni, Matteo ^c   Farfariello, Valerio ^a,d   Santoni, Giorgio ^a  

^a UNIVERSITY OF CAMERINO   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^d UNIVERSITY OF PERUGIA   (Italy)

Author keywords

Hematologic malignancies; Ion channels; Leukemia; Lymphoma; Multiple myeloma; Transient receptor potential channel family

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; POLYCYSTIN 1; TRANSIENT RECEPTOR POTENTIAL CHANNEL; TRANSIENT RECEPTOR POTENTIAL CHANNEL 1; TRANSIENT RECEPTOR POTENTIAL CHANNEL 3; TRANSIENT RECEPTOR POTENTIAL CHANNEL 6; TRANSIENT RECEPTOR POTENTIAL CHANNEL 7; TRANSIENT RECEPTOR POTENTIAL CHANNEL C; TRANSIENT RECEPTOR POTENTIAL CHANNEL M; TRANSIENT RECEPTOR POTENTIAL CHANNEL M1; TRANSIENT RECEPTOR POTENTIAL CHANNEL M2; TRANSIENT RECEPTOR POTENTIAL CHANNEL M4; TRANSIENT RECEPTOR POTENTIAL CHANNEL M5; TRANSIENT RECEPTOR POTENTIAL CHANNEL M7; TRANSIENT RECEPTOR POTENTIAL CHANNEL M8; VANILLOID RECEPTOR; VANILLOID RECEPTOR 2; VANILLOID RECEPTOR 5; VANILLOID RECEPTOR 6;

ACUTE GRANULOCYTIC LEUKEMIA; APOPTOSIS; ARTICLE; B CELL LYMPHOMA; CELL DIFFERENTIATION; CELL PROLIFERATION; CHILDHOOD DISEASE; CHRONIC LYMPHATIC LEUKEMIA; GENE EXPRESSION; GENE FUNCTION; GENETIC POLYMORPHISM; GENETIC RISK; HEMATOLOGIC MALIGNANCY; HEMATOPOIETIC CELL; HUMAN; IMMUNOCOMPETENT CELL; IN VIVO STUDY; LYMPHATIC LEUKEMIA; MULTIPLE MYELOMA; PRIORITY JOURNAL; T CELL LYMPHOMA; ANIMAL; DRUG DEVELOPMENT; GENE EXPRESSION REGULATION; GENETICS; HEMATOLOGIC NEOPLASMS; METABOLISM; MOLECULARLY TARGETED THERAPY;

ANIMALS; DRUG DISCOVERY; GENE EXPRESSION REGULATION, NEOPLASTIC; HEMATOLOGIC NEOPLASMS; HUMANS; MOLECULAR TARGETED THERAPY; TRANSIENT RECEPTOR POTENTIAL CHANNELS;

EID: 84892620092     PISSN: 18744672     EISSN: 18744702     Source Type: Journal    
DOI: 10.2174/187446720603140415215431     Document Type: Article

References (120)

1. Clapham, D.E.; Montell, C.; Schultz, G.; Julius, D. International Union of Pharmacology. XLIII. Compendium of voltage-gated ion channels: transient receptor potential channels. Pharmacol. Rev., 2003, 55, 591-596.
2. Montell, C. The TRP superfamily of cation channels. Sci. STKE, 2005, 2005, re3.
3. Lawrence, T.S.; Ten Haken, R.K.; Giaccia, A. Principles of radiation oncology; DeVita, V.T.; Lawrence, T.S.; Rosenberg, S.A.; Eds.; Lippincott Williams and Wilkins: Philadelphia, Pennsylvania, 2008.
4. Guo, H.; Carlson, J.A.; Slominski, A. Role of TRPM in melanocytes and melanoma. Exp. Dermatol., 2012, 21, 650-654.
5. Giugliano, E.; Rege-Cambrin, G.; Scaravaglio, P.; Serra, A.; Wlodarska, I.; Emanuel, B.; Saglio, G.; Hagemeijer, A. MLL-AF6 fusion resulting from a new three-way translocation t(6;11;7) in a patient with acute myeloid leukemia. Leukemia, 2001, 15, 1674-1676.
6. Carter, R.N.; Tolhurst, G.; Walmsley, G.; Vizuete-Forster, M.; Miller, N.; Mahaut-Smith, M.P. Molecular and electrophysiological characterization of transient receptor potential ion channels in the primary murine megakaryocyte. J. Physiol. (Lond.), 2006, 576, 151-162.
7. Wehage, E.; Eisfeld, J.; Heiner, I.; Jüngling, E.; Zitt, C.; Lückhoff, A. Activation of the cation channel long transient receptor potential channel 2 (LTRPC2) by hydrogen peroxide. A splice variant reveals a mode of activation independent of ADP-ribose. J. Biol. Chem., 2002, 277, 23150-23156.
8. Zeng, X.; Sikka, S.C.; Huang, L.; Sun, C.; Xu, C.; Jia, D.; Abdel- Mageed, A.B.; Pottle, J.E.; Taylor, J.T.; Li, M. Novel role for the transient receptor potential channel TRPM2 in prostate cancer cell proliferation. Prostate Cancer Prostatic Dis., 2010, 13, 195-201.
9. Ishii, M.; Oyama, A.; Hagiwara, T.; Miyazaki, A.; Mori, Y.; Kiuchi, Y.; Shimizu, S. Facilitation of H2O2-induced A172 human glioblastoma cell death by insertion of oxidative stress-sensitive TRPM2 channels. Anticancer Res., 2007, 27, 3987-3992.
10. Kirchberger, T.; Moreau, C.; Wagner, G.K.; Fliegert, R.; Siebrands, C.C.; Nebel, M.; Schmid, F.; Harneit, A.; Odoardi, F.; Flügel, A.; Potter, B.V.L.; Guse, A.H. 8-Bromo-cyclic inosine diphosphoribose: towards a selective cyclic ADP-ribose agonist. Biochem. J., 2009, 422, 139-149.
11. Naziroǧlu, M.; ÇIǧ, B.; Doǧan, S.; Uǧuz, A.C.; Dilek, S.; Faouzi, D. 2.45-Gz wireless devices induce oxidative stress and proliferation through cytosolic Ca2+ influx in human leukemia cancer cells. Int. J. Radiat. Biol., 2012, 88, 449-456.
12. Zhang, W.; Chu, X.; Tong, Q.; Cheung, J.Y.; Conrad, K.; Masker, K.; Miller, B.A. A novel TRPM2 isoform inhibits calcium influx and susceptibility to cell death. J. Biol. Chem., 2003, 278, 16222-16229.
13. Xu, X.Z.; Moebius, F.; Gill, D.L.; Montell, C. Regulation of melastatin, a TRP-related protein, through interaction with a cytoplasmic isoform. Proc. Natl. Acad. Sci. USA, 2001, 98, 10692-10697.
14. Launay, P.; Cheng, H.; Srivatsan, S.; Penner, R.; Fleig, A.; Kinet, J.P. TRPM4 regulates calcium oscillations after T cell activation. Science, 2004, 306, 1374-1377.
15. Ashida, S.; Nakagawa, H.; Katagiri, T.; Furihata, M.; Iiizumi, M.; Anazawa, Y.; Tsunoda, T.; Takata, R.; Kasahara, K.; Miki, T.; Fujioka, T.; Shuin, T.; Nakamura, Y. Molecular features of the transition from prostatic intraepithelial neoplasia (PIN) to prostate cancer: genome-wide gene-expression profiles of prostate cancers and PINs. Cancer Res., 2004, 64, 5963-5972.
16. Liu, P.; Ramachandran, S.; Ali Seyed, M.; Scharer, C.D.; Laycock, N.; Dalton, W.B.; Williams, H.; Karanam, S.; Datta, M.W.; Jaye, D.L.; Moreno, C.S. Sex-determining region Y box 4 is a transforming oncogene in human prostate cancer cells. Cancer Res., 2006, 66, 4011-4019.
17. Singh, J.; Manickam, P.; Shmoish, M.; Natik, S.; Denyer, G.; Handelsman, D.; Gong, D.-W.; Dong, Q. Annotation of androgen dependence to human prostate cancer-associated genes by microarray analysis of mouse prostate. Cancer Lett., 2006, 237, 298-304.
18. Narayan, G.; Bourdon, V.; Chaganti, S.; Arias-Pulido, H.; Nandula, S.V.; Rao, P.H.; Gissmann, L.; Dürst, M.; Schneider, A.; Pothuri, B.; Mansukhani, M.; Basso, K.; Chaganti, R.S. K.; Murty, V.V. Gene dosage alterations revealed by cDNA microarray analysis in cervical cancer: identification of candidate amplified and overexpressed genes. Genes Chromosomes Cancer, 2007, 46, 373-384.
19. Suguro, M.; Tagawa, H.; Kagami, Y.; Okamoto, M.; Ohshima, K.; Shiku, H.; Morishima, Y.; Nakamura, S.; Seto, M. Expression profiling analysis of the CD5+ diffuse large B-cell lymphoma subgroup: development of a CD5 signature. Cancer Sci., 2006, 97, 868-874.
20. Vennekens, R.; Nilius, B. Insights into TRPM4 function, regulation and physiological role. Handb. Exp. Pharmacol., 2007, 269-285.
21. Vennekens, R.; Olausson, J.; Meissner, M.; Bloch, W.; Mathar, I.; Philipp, S.E.; Schmitz, F.; Weissgerber, P.; Nilius, B.; Flockerzi, V.; Freichel, M. Increased IgE-dependent mast cell activation and anaphylactic responses in mice lacking the calcium-activated nonselective cation channel TRPM4. Nat. Immunol., 2007, 8, 312-320.
22. Barbet, G.; Demion, M.; Moura, I.C.; Serafini, N.; Léger, T.; Vrtovsnik, F.; Monteiro, R.C.; Guinamard, R.; Kinet, J.-P.; Launay, P. The calcium-activated nonselective cation channel TRPM4 is essential for the migration but not the maturation of dendritic cells. Nat. Immunol., 2008, 9, 1148-1156.
23. Shimizu, T.; Owsianik, G.; Freichel, M.; Flockerzi, V.; Nilius, B.; Vennekens, R. TRPM4 regulates migration of mast cells in mice. Cell Calcium, 2009, 45, 226-232.
24. Wong, N.A.; Pignatelli, M. Beta-catenin--a linchpin in colorectal carcinogenesis? Am. J. Pathol., 2002, 160, 389-401.
25. Logan, C.Y.; Nusse, R. The Wnt signaling pathway in development and disease. Annu. Rev. Cell Dev. Biol., 2004, 20, 781-810.
26. Tsutsui, J.; Moriyama, M.; Arima, N.; Ohtsubo, H.; Tanaka, H.; Ozawa, M. Expression of cadherin-catenin complexes in human leukemia cell lines. J. Biochem., 1996, 120, 1034-1039.
27. Chung, E.J.; Hwang, S.-G.; Nguyen, P.; Lee, S.; Kim, J.-S.; Kim, J.W.; Henkart, P.A.; Bottaro, D.P.; Soon, L.; Bonvini, P.; Lee, S.- J.; Karp, J.E.; Oh, H.J.; Rubin, J.S.; Trepel, J.B. Regulation of leukemic cell adhesion, proliferation, and survival by beta-catenin. Blood, 2002, 100, 982-990.
28. Armisén, R.; Marcelain, K.; Simon, F.; Tapia, J.C.; Toro, J.; Quest, A.F.; Stutzin, A. TRPM4 enhances cell proliferation through upregulation of the β-catenin signaling pathway. J. Cell Physiol., 2011, 226, 103-109.
29. Zhang, X.L.; Komada, Y.; Chipeta, J.; Li, Q.S.; Inaba, H.; Azuma, E.; Yamamoto, H.; Sakurai, M. Intracellular cytokine profile of T cells from children with acute lymphoblastic leukemia. Cancer Immunol. Immunother., 2000, 49, 165-172.
30. Duramad, P.; Tager, I.B.; Holland, N.T. Cytokines and other immunological biomarkers in children's environmental health studies. Toxicol. Lett., 2007, 172, 48-59.
31. Greaves, M. The causation of childhood leukemia: a paradox of progress? Discov. Med., 2006, 6, 24-28.
32. Han, S.; Koo, H.H.; Lan, Q.; Lee, K.M.; Park, A.K.; Park, S.K.; Sung, H.; Ahn, H.S.; Shin, H.Y.; Kang, H.J.; Seo, J.J.; Ahn, Y.-O.; Kim, H.; Rothman, N.; Kang, D. Common variation in genes related to immune response and risk of childhood leukemia. Hum. Immunol., 2012, 73, 316-319.
33. Monni, O.; Knuutila, S. 11q deletions in hematological malignancies. Leuk. Lymphoma, 2001, 40, 259-266.
34. Takeuchi, S.; Cho, S.K.; Seriu, T.; Koike, M.; Bartram, C.R.; Reiter, A.; Schrappe, M.; Takeuchi, C.; Taguchi, H.; Koeffler, H.P. Identification of three distinct regions of deletion on the long arm of chromosome 11 in childhood acute lymphoblastic leukemia. Oncogene, 1999, 18, 7387-7388.
35. Aster, J.C.; Pear, W.S.; Blacklow, S.C. Notch signaling in leukemia. Annu. Rev. Pathol., 2008, 3, 587-613.
36. Liu, D.; Zhang, Z.; Liman, E.R. Extracellular acid block and acidenhanced inactivation of the Ca2+-activated cation channel TRPM5 involve residues in the S3-S4 and S5-S6 extracellular domains. J. Biol. Chem., 2005, 280, 20691-20699.
37. Schlingmann, K.P.; Waldegger, S.; Konrad, M.; Chubanov, V.; Gudermann, T. TRPM6 and TRPM7--Gatekeepers of human magnesium metabolism. Biochim. Biophys. Acta, 2007, 1772, 813-821.
38. Jiang, H.; Tian, S.-L.; Zeng, Y.; Li, L.-L.; Shi, J. TrkA pathway(s) is involved in regulation of TRPM7 expression in hippocampal neurons subjected to ischemic-reperfusion and oxygen-glucose deprivation. Brain Res. Bull., 2008, 76, 124-130.
39. Du, J.; Xie, J.; Zhang, Z.; Tsujikawa, H.; Fusco, D.; Silverman, D.; Liang, B.; Yue, L. TRPM7-mediated Ca2+ signals confer fibrogenesis in human atrial fibrillation. Circ. Res., 2010, 106, 992-1003.
40. Clark, K.; Langeslag, M.; Van Leeuwen, B.; Ran, L.; Ryazanov, A.G.; Figdor, C.G.; Moolenaar, W.H.; Jalink, K.; Van Leeuwen, F.N. TRPM7, a novel regulator of actomyosin contractility and cell adhesion. EMBO J., 2006, 25, 290-301.
41. Jiang, J.; Li, M.-H.; Inoue, K.; Chu, X.-P.; Seeds, J.; Xiong, Z.-G. Transient receptor potential melastatin 7-like current in human head and neck carcinoma cells: role in cell proliferation. Cancer Res., 2007, 67, 10929-10938.
42. Kim, M.S.; Zeng, W.; Yuan, J.P.; Shin, D.M.; Worley, P.F.; Muallem, S. Native Store-operated Ca2+ Influx Requires the Channel Function of Orai1 and TRPC1. J. Biol. Chem., 2009, 284, 9733-9741.
43. Guilbert, A.; Gautier, M.; Dhennin-Duthille, I.; Haren, N.; Sevestre, H.; Ouadid-Ahidouch, H. Evidence that TRPM7 is required for breast cancer cell proliferation. Am. J. Physiol., Cell Physiol., 2009, 297, C493-502.
44. Zierler, S.; Yao, G.; Zhang, Z.; Kuo, W.C.; Porzgen, P.; Penner, R.; Horgen, F.D.; Fleig, A. Waixenicin A Inhibits Cell Proliferation through Magnesium-dependent Block of Transient Receptor Potential Melastatin 7 (TRPM7) Channels. J. Biol. Chem., 2011, 286, 39328-39335.
45. Nadler, M.J.; Hermosura, M.C.; Inabe, K.; Perraud, A.L.; Zhu, Q.; Stokes, A.J.; Kurosaki, T.; Kinet, J.P.; Penner, R.; Scharenberg, A.M.; Fleig, A. LTRPC7 is a Mg.ATP-regulated divalent cation channel required for cell viability. Nature, 2001, 411, 590-595.
46. Ng, N.M.; Jiang, S.P.; Lv, Z.Q. Retrovirus-mediated siRNA targeting TRPM7 gene induces apoptosis in RBL-2H3 cells. Eur. Rev. Med. Pharmacol. Sci., 2012, 16, 1172-1178.
47. Sahni, J.; Scharenberg, A.M. TRPM7 ion channels are required for sustained phosphoinositide 3-kinase signaling in lymphocytes. Cell Metab., 2008, 8, 84-93.
48. Abed, E.; Moreau, R. Importance of melastatin-like transient receptor potential 7 and magnesium in the stimulation of osteoblast proliferation and migration by platelet-derived growth factor. Am. J. Physiol., Cell Physiol., 2009, 297, C360-C368.
49. Mason, M.J.; Schaffner, C.; Floto, R.A.; Teo, Q.A. Constitutive expression of a Mg2+-inhibited K+ current and a TRPM7-like current in human erythroleukemia cells. Am. J. Physiol. Cell Physiol., 2011, 302, C853-C867.
50. Matsuda, H.; Saigusa, A.; Irisawa, H. Ohmic conductance through the inwardly rectifying K channel and blocking by internal Mg2+. Nature, 1987, 325, 156-159.
51. Kozak, J.A.; Matsushita, M.; Nairn, A.C.; Cahalan, M.D. Charge screening by internal pH and polyvalent cations as a mechanism for activation, inhibition, and rundown of TRPM7/MIC channels. J. Gen. Physiol., 2005, 126, 499-514.
52. Kozak, J.A.; Cahalan, M.D. MIC channels are inhibited by internal divalent cations but not ATP. Biophys. J., 2003, 84, 922-927.
53. McKemy, D.D.; Neuhausser, W.M.; Julius, D. Identification of a cold receptor reveals a general role for TRP channels in thermosensation. Nature, 2002, 416, 52-58.
54. Peier, A.M.; Moqrich, A.; Hergarden, A.C.; Reeve, A.J.; Andersson, D.A.; Story, G.M.; Earley, T.J.; Dragoni, I.; McIntyre, P.; Bevan, S.; Patapoutian, A. A TRP channel that senses cold stimuli and menthol. Cell, 2002, 108, 705-715.
55. Colburn, R.W.; Lubin, M.L.; Stone, D.J. Jr; Wang, Y.; Lawrence, D.; D'Andrea, M.R.; Brandt, M.R.; Liu, Y.; Flores, C.M.; Qin, N. Attenuated cold sensitivity in TRPM8 null mice. Neuron, 2007, 54, 379-386.
56. Dhaka, A.; Murray, A.N.; Mathur, J.; Earley, T.J.; Petrus, M.J.; Patapoutian, A. TRPM8 is required for cold sensation in mice. Neuron, 2007, 54, 371-378.
57. Cho, Y.; Jang, Y.; Yang, Y.D.; Lee, Y.; Oh, U. TRPM8 mediates cold and menthol allergies associated with mast cell activation. Cell Calcium, 2010, 48, 202-208.
58. Park, K.S.; Pang, B.; Park, S.J.; Lee, Y.-G.; Bae, J.-Y.; Park, S.; Kim, I.; Kim, S.J. Identification and functional characterization of ion channels in CD34(+) hematopoietic stem cells from human peripheral blood. Mol. Cells, 2011, 32, 181-188.
59. Boyd, R.S.; Jukes-Jones, R.; Walewska, R.; Brown, D.; Dyer, M.J.; Cain, K. Protein profiling of plasma membranes defines aberrant signaling pathways in mantle cell lymphoma. Mol. Cell Proteomics., 2009, 8, 1501-1515.
60. Kanzaki, M.; Zhang, Y.Q.; Mashima, H.; Li, L.; Shibata, H.; Kojima, I. Translocation of a calcium-permeable cation channel induced by insulin-like growth factor-I. Nat. Cell Biol., 1999, 1, 165-170.
61. Bubien, J.K.; Zhou, L.J.; Bell, P.D.; Frizzell, R.A.; Tedder, T.F. Transfection of the CD20 cell surface molecule into ectopic cell types generates a Ca2+ conductance found constitutively in B lymphocytes. J. Cell Biol., 1993, 121, 1121-1132.
62. Tedder, T.F.; Engel, P. CD20: a regulator of cell-cycle progression of B lymphocytes. Immunol. Today, 1994, 15, 450-454.
63. Su, A.I.; Wiltshire, T.; Batalov, S.; Lapp, H.; Ching, K.A.; Block, D.; Zhang, J.; Soden, R.; Hayakawa, M.; Kreiman, G.; Cooke, M.P.; Walker, J.R.; Hogenesch, J.B. A gene atlas of the mouse and human protein-encoding transcriptomes. Proc. Natl. Acad. Sci. USA, 2004, 101, 6062-6067.
64. Fabris, S.; Todoerti, K.; Mosca, L.; Agnelli, L.; Intini, D.; Lionetti, M.; Guerneri, S.; Lambertenghi-Deliliers, G.; Bertoni, F.; Neri, A. Molecular and transcriptional characterization of the novel 17p11.2-p12 amplicon in multiple myeloma. Genes Chromosomes Cancer, 2007, 46, 1109-1118.
65. Zatkova, A.; Merk, S.; Wendehack, M.; Bilban, M.; Muzik, E.M.; Muradyan, A.; Haferlach, C.; Haferlach, T.; Wimmer, K.; Fonatsch, C.; Ullmann, R. AML/MDS with 11q/ MLL amplification show characteristic gene expression signature and interplay of DNA copy number changes. Genes Chromosomes Cancer, 2009, 48, 510-520.
66. Caprodossi, S.; Lucciarini, R.; Amantini, C.; Nabissi, M.; Canesin, G.; Ballarini, P.; Di Spilimbergo, A.; Cardarelli, M.A.; Servi, L.; Mammana, G.; Santoni, G. Transient receptor potential vanilloid type 2 (TRPV2) expression in normal urothelium and in urothelial carcinoma of human bladder: correlation with the pathologic stage. Eur. Urol., 2008, 54, 612-620.
67. Nagasawa, M.; Nakagawa, Y.; Tanaka, S.; Kojima, I. Chemotactic peptide fMetLeuPhe induces translocation of the TRPV2 channel in macrophages. J. Cell Physiol., 2007, 210, 692-702.
68. Vasil'eva, I.O.; Neguliaev, I.A.; Marakhova, I.I.; Semenova, S.B. TRPV5 and TRPV6 calcium channels in human T cells. Tsitologiia, 2008, 50, 953-957.
69. Peng, J.B.; Chen, X.Z.; Berger, U.V.; Weremowicz, S.; Morton, C.C.; Vassilev, P.M.; Brown, E.M.; Hediger, M.A. Human calcium transport protein CaT1. Biochem. Biophys. Res. Commun., 2000, 278, 326-332.
70. Semenova, S.B.; Vassilieva, I.O.; Fomina, A.F.; Runov, A.L.; Negulyaev, Y.A. Endogenous expression of TRPV5 and TRPV6 calcium channels in human leukemia K562 cells. Am. J. Physiol. Cell Physiol., 2009, 296, C1098-C1104.
71. Cui, J.; Bian, J.-S.; Kagan, A.; McDonald, T.V. CaT1 contributes to the stores-operated calcium current in Jurkat T-lymphocytes. J. Biol. Chem., 2002, 277, 47175-47183.
72. Hoenderop, J.G.J.; Voets, T.; Hoefs, S.; Weidema, F.; Prenen, J.; Nilius, B.; Bindels, R.J.M. Homo- and heterotetrameric architecture of the epithelial Ca2+ channels TRPV5 and TRPV6. EMBO J., 2003, 22, 776-785.
73. Hoenderop, J.G.J.; Dardenne, O.; Van Abel, M.; Van Der Kemp, A.W.C.M.; Van Os, C.H.; St-Arnaud, R.; Bindels, R.J.M. Modulation of renal Ca2+ transport protein genes by dietary Ca2+ and 1,25-dihydroxyvitamin D3 in 25-hydroxyvitamin D3-1alphahydroxylase knockout mice. FASEB J., 2002, 16, 1398-1406.
74. Owen, T.A.; Aronow, M.S.; Barone, L.M.; Bettencourt, B.; Stein, G.S.; Lian, J.B. Pleiotropic effects of vitamin D on osteoblast gene expression are related to the proliferative and differentiated state of the bone cell phenotype: dependency upon basal levels of gene expression, duration of exposure, and bone matrix competency in normal rat osteoblast cultures. Endocrinology, 1991, 128, 1496-1504.
75. Miyaura, C.; Abe, E.; Suda, T. Extracellular calcium is involved in the mechanism of differentiation of mouse myeloid leukemia cells (M1) induced by 1 alpha, 25-dihydroxyvitamin D3. Endocrinology, 1984, 115, 1891-1896.
76. Lehen'kyi, V.; Flourakis, M.; Skryma, R.; Prevarskaya, N. TRPV6 channel controls prostate cancer cell proliferation via Ca(2+)/NFAT-dependent pathways. Oncogene, 2007, 26, 7380-7385.
77. Kuro-o, M. Klotho as a regulator of oxidative stress and senescence. Biol. Chem., 2008, 389, 233-241.
78. Chang, Q.; Hoefs, S.; Van der Kemp, A.W.; Topala, C.N.; Bindels, R.J.; Hoenderop, J.G. The beta-glucuronidase klotho hydrolyzes and activates the TRPV5 channel. Science, 2005, 310, 490-493.
79. Cha, S.-K.; Ortega, B.; Kurosu, H.; Rosenblatt, K.P.; Kuro O.M.; Huang, C.-L. Removal of sialic acid involving Klotho causes cellsurface retention of TRPV5 channel via binding to galectin-1. Proc. Natl. Acad. Sci. USA, 2008, 105, 9805-9810.
80. Lutomski, D.; Fouillit, M.; Bourin, P.; Mellottée, D.; Denize, N.; Pontet, M.; Bladier, D.; Caron, M.; Joubert-Caron, R. Externalization and binding of galectin-1 on cell surface of K562 cells upon erythroid differentiation. Glycobiology, 1997, 7, 1193-1199.
81. Vassilieva, I.O.; Tomilin, V.N.; Marakhova, I.I.; Shatrova, A.N.; Negulyaev, Y.A.; Semenova, S.B. Expression of Transient Receptor Potential Vanilloid Channels TRPV5 and TRPV6 in Human Blood Lymphocytes and Jurkat Leukemia T Cells. J. Membr. Biol., 2012, 246, 131-140.
82. Bodding, M. The Recombinant Human TRPV6 Channel Functions as Ca2+ Sensor in Human Embryonic Kidney and Rat Basophilic Leukemia Cells. J. Biol. Chem., 2002, 277, 36656-36664.
83. Rao, G.K.; Kaminski, N.E. Induction of intracellular calcium elevation by 9-tetrahydrocannabinol in T cells involves TRPC1 channels. J. Leukoc. Biol., 2006, 79, 202-213.
84. Kaplan, B.L.F.; Rockwell, C.E.; Kaminski, N.E. Evidence for cannabinoid receptor-dependent and -independent mechanisms of action in leukocytes. J. Pharmacol. Exp. Ther., 2003, 306, 1077-1085.
85. Harding, F.A.; McArthur, J.G.; Gross, J.A.; Raulet, D.H.; Allison, J.P. CD28-mediated signalling co-stimulates murine T cells and prevents induction of anergy in T-cell clones. Nature, 1992, 356, 607-609.
86. Nakayama, T.; Ueda, Y.; Yamada, H.; Shores, E.W.; Singer, A.; June, C.H. In vivo calcium elevations in thymocytes with T cell receptors that are specific for self ligands. Science, 1992, 257, 96-99.
87. Huang, G.N.; Zeng, W.; Kim, J.Y.; Yuan, J.P.; Han, L.; Muallem, S.; Worley, P.F. STIM1 carboxyl-terminus activates native SOC, I(crac) and TRPC1 channels. Nat. Cell Biol., 2006, 8, 1003-1010.
88. Philipp, S. TRPC3 Mediates T-cell Receptor-dependent Calcium Entry in Human T-lymphocytes. J. Biol. Chem., 2003, 278, 26629-26638.
89. Gamberucci, A.; Giurisato, E.; Pizzo, P.; Tassi, M.; Giunti, R.; McIntosh, D.P.; Benedetti, A. Diacylglycerol activates the influx of extracellular cations in T-lymphocytes independently of intracellular calcium-store depletion and possibly involving endogenous TRP6 gene products. Biochem. J., 2002, 364, 245-254.
90. Carrillo, C.; Hichami, A.; Andreoletti, P.; Cherkaoui-Malki, M.; Del Mar Cavia, M.; Abdoul-Azize, S.; Alonso-Torre, S.R.; Khan, N.A. Diacylglycerol-containing oleic acid induces increases in [Ca(2+)](i) via TRPC3/6 channels in human T-cells. Biochim. Biophys. Acta, 2012, 1821, 618-626.
91. Tseng, P.-H.; Lin, H.-P.; Hu, H.; Wang, C.; Zhu, M.X.; Chen, C.-S. The canonical transient receptor potential 6 channel as a putative phosphatidylinositol 3,4,5-trisphosphate-sensitive calcium entry system. Biochemistry, 2004, 43, 11701-11708.
92. Wenning, A.S.; Neblung, K.; Strauß, B.; Wolfs, M.-J.; Sappok, A.; Hoth, M.; Schwarz, E.C. TRP expression pattern and the functional importance of TRPC3 in primary human T-cells. Biochim. Biophys. Acta, 2011, 1813, 412-423.
93. Pang, B.; Shin, D.H.; Park, K.S.; Huh, Y.J.; Woo, J.; Zhang, Y.-H.; Kang, T.M.; Lee, K.-Y.; Kim, S.J. Differential pathways for calcium influx activated by concanavalin A and CD3 stimulation in Jurkat T cells. Pflugers Arch., 2012, 463, 309-318.
94. Sano, Y.; Inamura, K.; Miyake, A.; Mochizuki, S.; Yokoi, H.; Matsushime, H.; Furuichi, K. Immunocyte Ca2+ Influx System Mediated by LTRPC2. Science, 2001, 293, 1327-1330.
95. Perraud, A.L.; Fleig, A.; Dunn, C.A.; Bagley, L.A.; Launay, P.; Schmitz, C.; Stokes, A.J.; Zhu, Q.; Bessman, M.J.; Penner, R.; Kinet, J.P.; Scharenberg, A.M. ADP-ribose gating of the calciumpermeable LTRPC2 channel revealed by Nudix motif homology. Nature, 2001, 411, 595-599.
96. Föller, M.; Kasinathan, R.S.; Duranton, C.; Wieder, T.; Huber, S.M.; Lang, F. PGE2-induced apoptotic cell death in K562 human leukaemia cells. Cell. Physiol. Biochem. 2006, 17, 201-210.
97. Sheu, M.L.; Ho, F.M.; Yang, R.S.; Chao, K.F.; Lin, W.W.; Lin- Shiau, S.Y.; Liu, S.-H. High glucose induces human endothelial cell apoptosis through a phosphoinositide 3-kinase-regulated cyclooxygenase- 2 pathway. Arterioscler. Thromb. Vasc. Biol., 2005, 25, 539-545.
98. Tessner, T.G.; Muhale, F.; Riehl, T.E.; Anant, S.; Stenson, W.F. Prostaglandin E2 reduces radiation-induced epithelial apoptosis through a mechanism involving AKT activation and bax translocation. J. Clin. Invest., 2004, 114, 1676-1685.
99. Aguiari, G.; Piva, R.; Manzati, E.; Mazzoni, E.; Augello, G.; Chiari, E.; Moretti, S.; Neri, L. M.; Del Senno, L. K562 erythroid and HL60 macrophage differentiation downregulates polycystin, a large membrane-associated protein. Exp. Cell Res., 1998, 244, 259-267.
100. Birkenhäger, W.H.; De Leeuw, P.W. Treatment of the elderly hypertensive: A clinical perspective. Eur. Heart J., 1988, 9, 63-67.
101. Kochegarov, A.A. Pharmacological modulators of voltage-gated calcium channels and their therapeutical application. Cell Calcium, 2003, 33, 145-162.
102. Scharff, O.; Foder, B. Regulation of cytosolic calcium in blood cells. Physiol Rev., 1993, 73, 547-582.
103. Shirakawa, F.; Yamashita, U.; Oda, S.; Chiba, S.; Eto, S.; Suzuki, H. Calcium dependency in the growth of adult T-cell leukemia cells in vitro. Cancer Res., 1986, 46, 658-661.
104. Vilpo, J.; Koski, T.; Vilpo, L. Calcium antagonists potentiate Pglycoprotein- independent anticancer drugs in chronic lymphocytic leukemia cells in vitro. Haematologica, 2000, 85, 806-813.
105. Soboloff, J.; Zhang, Y.; Minden, M.; Berger, S.A. Sensitivity of myeloid leukemia cells to calcium influx blockade: application to bone marrow purging. Exp Hematol., 2002, 30, 1219-1226.
106. Conrad, D.M.; Furlong, S.J.; Doucette, C.D.; West, K.A.; Hoskin, D.W. The Ca(2+) channel blocker flunarizine induces caspase-10- dependent apoptosis in Jurkat T-leukemia cells. Apoptosis, 2010, 15, 597-607.
107. Santoni, G.; Farfariello, V.; Amantini, C. TRPV channels in tumor growth and progression. Adv. Exp. Med. Biol., 2011, 704, 947-967.
108. Takezawa, R.; Cheng, H.; Beck, A.; Ishikawa, J.; Launay, P.; Kubota, H.; Kinet, J.-P.; Fleig, A.; Yamada, T.; Penner, R. A Pyrazole Derivative Potently Inhibits Lymphocyte Ca2+ Influx and Cytokine Production by Facilitating Transient Receptor Potential Melastatin 4 Channel Activity. Mol. Pharmacol., 2006, 69, 1413-1420.
109. Li, M.; Jiang, J.; Yue, L. Functional characterization of homo- and heteromeric channel kinases TRPM6 and TRPM7. J. Gen. Physiol., 2006, 127, 525-537.
110. Liang, J.; Slingerland, J.M. Multiple roles of the PI3K/PKB (Akt) pathway in cell cycle progression. Cell Cycle, 2003, 2, 339-345.
111. Lu, H.F.; Hsueh, S.C.; Yu, F.S.; Yang, J.S.; Tang, N.Y.; Chen, S.C.; Chung, J.G. The Role of Ca2+ in (-)-Menthol-induced Human Promyelocytic Leukemia HL-60 Cell Death. In vivo, 2006, 20, 69-75.
112. Lu, H.F.; Liu, J.Y.; Hsueh, S.C.; Yang, Y.Y.; Yang, J.S.; Tan, T.W.; Kok, L.F.; Lu, C.C.; Lan, S.H.; Wu, S.Y.; Liao, S.S.; Ip, S.W.; Chung, J.G. (-)-Menthol inhibits WEHI-3 leukemia cells in vitro and in vivo. In vivo, 2007, 21, 285-289.
113. Santoni, G.; Farfariello, V.; Liberati, S.; Morelli, M.B.; Nabissi, M.; Santoni, M.; Amantini, C. The role of transient receptor potential vanilloid type-2 ion channels in innate and adaptive immune responses. Front. Immunol., 2013, 4, 34.
114. Morelli, M.B.; Offidani, M.; Discepoli, G.; Santoni, M.; Amantini, C.; Farfariello, V.; Liberati, S.; Leoni, P.; Santoni, G.; Nabissi, M. Role of the Transient Receptor Potential Vanilloid-type2 Agonist Cannabidiol in Multiple Mieloma. 6th European Workshop on Cannabinoid Research, Dublin, P016, April 18-20, 2013.
115. Heise, N.; Palme, D.; Misovic, M.; Koka, S.; Rudner, J.; Lang, F.; Salih, H.R.; Huber, S. M.; Henke, G. Non-Selective Cation Channel- Mediated Ca2+-Entry and Activation of Ca2+/Calmodulin- Dependent Kinase II Contribute to G2/M Cell Cycle Arrest and Survival of Irradiated Leukemia Cells. Cell. Physiol. Biochem., 2010, 26, 597-608.
116. Böhmer, C.; Palmada, M.; Kenngott, C.; Lindner, R.; Klaus, F.; Laufer, J.; Lang, F. Regulation of the epithelial calcium channel TRPV6 by the serum and glucocorticoid-inducible kinase isoforms SGK1 and SGK3. FEBS Lett., 2007, 581, 5586-5590.
117. Palmada, M.; Poppendieck, S.; Embark, H. M.; Van de Graaf, S.F.J.; Boehmer, C.; Bindels, R.J.M.; Lang, F. Requirement of PDZ domains for the stimulation of the epithelial Ca2+ channel TRPV5 by the NHE regulating factor NHERF2 and the serum and glucocorticoid inducible kinase SGK1. Cell. Physiol. Biochem., 2005, 15, 175-182.
118. Embark, H.M.; Setiawan, I.; Poppendieck, S.; Van de Graaf, S.F.J.; Boehmer, C.; Palmada, M.; Wieder, T.; Gerstberger, R.; Cohen, P.; Yun, C.C.; Bindels, R.J.M.; Lang, F. Regulation of the epithelial Ca2+ channel TRPV5 by the NHE regulating factor NHERF2 and the serum and glucocorticoid inducible kinase isoforms SGK1 and SGK3 expressed in Xenopus oocytes. Cell. Physiol. Biochem., 2004, 14, 203-212.
119. Nilius, B.; Owsianik, G.; Voets, T. Transient receptor potential channels meet phosphoinositides. EMBO J., 2008, 27, 2809-2816.
120. Si, J.; Collins, S.J. Activated Ca2+/calmodulin-dependent protein kinase IIgamma is a critical regulator of myeloid leukemia cell proliferation. Cancer Res., 2008, 68, 3733-3742.